Your browser doesn't support javascript.
loading
When to withhold oral anticoagulation in atrial fibrillation - an overview of frequent clinical discussion topics.
Seelig, Jaap; Pisters, Ron; Hemels, Martin E; Huisman, Menno V; Ten Cate, Hugo; Alings, Marco.
Afiliação
  • Seelig J; Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands.
  • Pisters R; Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands.
  • Hemels ME; Department of Cardiology, Rijnstate Hospital, Arnhem, The Netherlands.
  • Huisman MV; Department of Cardiology, Radboud University Medical Center, Nijmegen, The Netherlands.
  • Ten Cate H; Department of Thrombosis and Hemostasis, Leiden University Medical Center, Leiden, The Netherlands.
  • Alings M; Department of Internal Medicine, Cardiovascular Research Institute Maastricht, Maastricht, The Netherlands.
Vasc Health Risk Manag ; 15: 399-408, 2019.
Article em En | MEDLINE | ID: mdl-31571891

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral / Suspensão de Tratamento / Hemorragia / Anticoagulantes Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Fibrilação Atrial / Acidente Vascular Cerebral / Suspensão de Tratamento / Hemorragia / Anticoagulantes Tipo de estudo: Diagnostic_studies / Etiology_studies / Prognostic_studies / Qualitative_research / Risk_factors_studies Limite: Humans Idioma: En Ano de publicação: 2019 Tipo de documento: Article